| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) (NCT03563326) | Jian-Kun Hu | 2018-08-30 |
| Surgical Treatment of Pancreatic RCC Metastases (NCT03670992) | Azienda Policlinico Umberto I | 2016-01-10 |
| Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain Metastases (NCT02265549) | Maastricht Radiation Oncology | 2014-05-01 |
| A Study in Patients With Advanced or Metastatic Cancer (NCT01115751) | Eli Lilly and Company | 2010-03-01 |
| Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. (NCT00065117) | AstraZeneca | 2003-09-01 |
| A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer (NCT00055471) | AstraZeneca | 2003-06-01 |
| Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED) (NCT00050336) | Merck Sharp & Dohme LLC | 2002-12-01 |
| Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer (NCT00048893) | National Cancer Institute (NCI) | 2002-11-01 |
| Study of Erbitux (Cetuximab) in Patients With Metastatic Colorectal Carcinoma (NCT00044863) | Eli Lilly and Company | 2002-08-01 |
| This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer (NCT00034918) | Genzyme, a Sanofi Company | 2002-05-01 |
| High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors (NCT00037869) | M.D. Anderson Cancer Center | 2001-11-01 |
| Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel (NCT00039780) | BioNumerik Pharmaceuticals, Inc. | 2001-09-01 |
| Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver (NCT00041808) | FeRx | 2001-07-01 |
| ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer (NCT00046514) | Celgene Corporation | 2001-06-01 |
| Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer (NCT00046527) | Celgene Corporation | 2001-06-01 |
| Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients (NCT00037609) | M.D. Anderson Cancer Center | 2001-01-01 |
| A Trial of ABI-007 in Patients With Advanced Non-Hematologic Malignancies (NCT00046423) | Celgene Corporation | 2000-04-01 |
| Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole (NCT00038038) | M.D. Anderson Cancer Center | 1994-01-01 |
| Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer (NCT00040560) | Copharos | |
| A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. (NCT00035035) | Eli Lilly and Company | |
| Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) (NCT00054795) | Pharmacyclics LLC. | |
| A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium (NCT00035061) | Eli Lilly and Company | |